Journal
BRITISH JOURNAL OF CANCER
Volume 118, Issue 6, Pages 813-819Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/bjc.2017.497
Keywords
breast cancer; epithelial-mesenchymal plasticity; intratumoural heterogeneity; CD9
Categories
Funding
- Ministry of Health of the Czech Republic [15-33999A]
- National Program of Sustainability II (MEYS CR) [LQ1605]
Ask authors/readers for more resources
Background: The intratumoural heterogeneity, often driven by epithelial-to-mesenchymal transition (EMT), significantly contributes to chemoresistance and disease progression in adenocarcinomas. Methods: We introduced a high-throughput screening platform to identify surface antigens that associate with epithelial-mesenchymal plasticity in well-defined pairs of epithelial cell lines and their mesenchymal counterparts. Using multicolour flow cytometry, we then analysed the expression of 10 most robustly changed antigens and identified a 10-molecule surface signature, in pan-cytokeratin-positive/EpCAM-positive and -negative fractions of dissociated breast tumours. Results: We found that surface CD9, CD29, CD49c, and integrin beta 5 are lost in breast cancer cells that underwent EMT in vivo. The tetraspanin family member CD9 was concordantly downregulated both in vitro and in vivo and associated with epithelial phenotype and favourable prognosis. Conclusions: We propose that overall landscape of 10-molecule surface signature expression reflects the epithelial-mesenchymal plasticity in breast cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available